SPY313.14+2.62 0.84%
DIA259.26+1.95 0.76%
IXIC10,247.78+93.15 0.92%

UBS Maintains Neutral on Surgery Partners, Raises Price Target to $12

UBS maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and raises the price target from $7.5 to $12.

Benzinga · -

UBS maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and raises the price target from $7.5 to $12.